Seroprevalence of SARS-CoV-2 antibodies among public transport workers in Sweden
Journal article, 2022

Introduction: Public transportation is an essential societal function in crisis situations like the coronavirus disease 2019 (COVID-19) pandemic. Bus drivers and other public transport workers are essential workers that need to keep working despite the risk of contagion. The SARS-CoV-2 virus may pose an occupational health risk to public transport workers and especially to bus drivers as they interact with passengers in a confined area. By analyzing antibodies towards SARS-CoV-2 proteins in blood samples it is possible to measure if an individual has been infected by COVID-19. Here, we report the prevalence of antibodies among bus drivers and other public transport employees in Stockholm, Sweden and relate it to socio-demographic factors. Methods: Seroprevalence of IgG antibodies towards SARS-CoV-2 proteins was investigated in a sample of 262 non-vaccinated public transport workers (182 men and 40 women) recruited between April 26 and May 7, 2021. Most of the participants were bus drivers (n = 222). The relationship between socio-demographic factors and seroprevalence was investigated with logistic regression. Results: The seroprevalence was 50% in the total sample of public transport workers. Among bus drivers, 51% were seropositive compared to 44% seropositive among the other public transport workers. The difference was not significant. The seroprevalence was higher than the national seroprevalence in Sweden during the same period (18.3% in non-vaccinated people aged 20–64 years). The logistic regression model using Wald forward selection showed that men had a higher risk of being seropositive (OR 2.7, 95% CI 1.3 – 5.8) and there was a higher risk with increasing number of people in the household (OR 1.3, 95% CI 1.1 – 1.6). Conclusions: These findings could imply an occupational risk for COVID-19 infection among public transport workers. Infection control measures are warranted during virus epidemics to assure bus drives’ safety and reduce transmission in public transport.

Public transport

SARS-CoV-2

COVID-19

Bus driver

Infection control

Seroprevalence

Author

Anna Sjörs

The Swedish National Road and Transport Research Institute (VTI)

Chalmers, Electrical Engineering, Signal Processing and Biomedical Engineering

Anna Anund

Linköping University

The Swedish National Road and Transport Research Institute (VTI)

Journal of Transport and Health

22141405 (ISSN)

Vol. 27 101508

Subject Categories

Transport Systems and Logistics

Environmental Health and Occupational Health

Public Health, Global Health, Social Medicine and Epidemiology

DOI

10.1016/j.jth.2022.101508

PubMed

36188635

More information

Latest update

10/25/2023